Sterile placement needles (17GA ETW x 20cm) with bone wax, (1.0 x 3mm) soft tiss
Sterile placement needles (17GA ETW x 20cm) with bone wax, (1.0 x 3mm) soft tissue gold marker coupled with 17mm spacer and (1.0 x 3mm) soft tissue gold marker [2]
Sterile placement needle (17GA ETW x 20cm) with bone wax, (1.0 x 3mm) soft tissu
Sterile placement needle (17GA ETW x 20cm) with bone wax, (1.0 x 3mm) soft tissue gold marker couple with 17mm spacer and (1.0 x 3mm) soft tissue gold marker (blue styl-loc) Sterile placement needle (17GA ETW x 20cm) with bone wax and (1.2 x 3mm) soft tissue gold marker (white styl-loc)
Sterile placement needle (17GA ETW x 20cm) with bone wax, (1.0 x 3mm) soft tissu
Sterile placement needle (17GA ETW x 20cm) with bone wax, (1.0 x 3mm) soft tissue gold marker coupled with 17mm spacer and (1.0 x 3mm) soft tissue gold marker
Sterile placement needles (18GA ETW x 20cm) with bone wax, (0.8 x 3mm) soft tiss
Sterile placement needles (18GA ETW x 20cm) with bone wax, (0.8 x 3mm) soft tissue gold marker coupled with 17mm spacer and (0.8 x 3mm) soft tissue gold marker [2]
(53cm x 143cm) overlay with MR T-pin Lok-Bar™s(4), Type 1B Bridge(2), Type 2 Bri
(53cm x 143cm) overlay with MR T-pin Lok-Bar™s(4), Type 1B Bridge(2), Type 2 Bridge(2), and Type 3 Bridge(1)
LNH,IYE
System, nuclear magnetic resonance imaging,Accelerator, linear, medical
(53cm x 210.8cm) overlay with T-Pin Lok-Bar™s(4), Type1B Bridge (2), Type 2 Brid
(53cm x 210.8cm) overlay with T-Pin Lok-Bar™s(4), Type1B Bridge (2), Type 2 Bridge (2), Type 3 Bridge (1) and 8" Clam-Lok™ Cushion(1)
IXQ,IYE
Table, radiographic, stationary top,Accelerator, linear, medical
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery during and before external radiotherapy treatment, including IMRT, VMAT and 4DRT (respiratory gating and tumour tracking)• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery during and before external radiotherapy treatment, including IMRT, VMAT and 4DRT (respiratory gating and tumour tracking)• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.